Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Device
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

The aim of the study is to determine whether or not extra-sheath steroid injections are inferior to intra-sheath steroid injections in the treatment of DeQuervain's Tenosynovitis. Patients will be randomized to either the intra-sheath group or the extra-sheath group and their pre-injection level of pain will be assessed using the visual analog scale. Appropriate injections will then be administered by 1 of 3 UC Davis hand surgeons. Six weeks post injection the patients will be reassessed using the visual analog scale and their score at 6 weeks will be compared to their pre-injection score.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Signed informed consent from the patient exclusively and not a legal representative

• Clinically diagnosed with De Quervain's

• VAS score of at least 40mm pre-injection

• Life expectancy greater than 1 year

Locations
United States
California
UC Davis Health, Department of Orthopaedics
RECRUITING
Sacramento
Contact Information
Primary
Julia Martin, MS
jyhmartin@ucdavis.edu
916-7348175
Backup
Christopher O Bayne, MD
cbayne@ucdavis.edu
(916) 734-2700
Time Frame
Start Date: 2022-01-24
Estimated Completion Date: 2025-06-01
Participants
Target number of participants: 80
Treatments
Active_comparator: Intra-sheath injection
In patients randomized to the intra-sheath, corticosteroids will be injected directly into the abductor pollicis longus/ extensor pollicis brevis sheath.
Experimental: Extra-sheath injection
In patients randomized to the extra-sheath arm, corticosteroids will be injected surrounding the abductor pollicis longus/ extensor pollicis brevis sheath.
Related Therapeutic Areas
Sponsors
Leads: University of California, Davis

This content was sourced from clinicaltrials.gov